These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28711713)

  • 41. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
    Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
    Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
    Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
    Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide.
    Peters C; Fernandez-Perez EJ; Burgos CF; Espinoza MP; Castillo C; Urrutia JC; Streltsov VA; Opazo C; Aguayo LG
    Neurobiol Aging; 2013 Dec; 34(12):2805-14. PubMed ID: 23855983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.
    Melnyk P; Vingtdeux V; Burlet S; Eddarkaoui S; Grosjean ME; Larchanché PE; Hochart G; Sergheraert C; Estrella C; Barrier M; Poix V; Plancq P; Lannoo C; Hamdane M; Delacourte A; Verwaerde P; Buée L; Sergeant N
    ACS Chem Neurosci; 2015 Apr; 6(4):559-69. PubMed ID: 25611616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
    Lee JY; Kim SB; Chun J; Song KH; Kim YS; Chung SJ; Cho HJ; Yoon IS; Kim DD
    Biopharm Drug Dispos; 2016 Apr; 37(3):156-67. PubMed ID: 26861967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
    Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
    Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
    Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
    Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
    Veloso AJ; Kerman K
    Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
    Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
    Viola KL; Sbarboro J; Sureka R; De M; Bicca MA; Wang J; Vasavada S; Satpathy S; Wu S; Joshi H; Velasco PT; MacRenaris K; Waters EA; Lu C; Phan J; Lacor P; Prasad P; Dravid VP; Klein WL
    Nat Nanotechnol; 2015 Jan; 10(1):91-8. PubMed ID: 25531084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
    Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
    J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.